Capsugel Launches New Oral Formulation Business Unit

By Dan Stanton

- Last updated on GMT

Capsugel announce new dosage form business unit
Capsugel announce new dosage form business unit
Capsugel says it will focus on lipid-based formulations as it launches a new Dosage Form Solutions Business Unit.

The new unit, based at the company’s headquarters in Morristown, New Jersey, will integrate formulation R&D with proprietary technology and commercial manufacturing as Capsugel aims to develop innovative products to address customer demand.

Amit Patel, who will serve as President of the Unit, said in a press release that “continuing to innovate and develop cutting-edge healthcare products is essential to maximizing the potential of the industry.”

Lipid-based Formulations

Patel also said that the new unit would focus on improvements in solid oral dosage products, including bioavailability enhancement and optimal dosing for potent APIs, and especially lipid-based formulations.

Lipid-based drug delivery systems (LBDDs) are an increasingly more important drug delivery technique as drugs become more complex and less soluble in water. LBDDs are a versatile way of enabling a higher dose to be encapsulated and more API to be absorbed.

Last June, Capsugel entered into a partnership with Quotient​ in order to boost its LBDDs know-how and two months later launched a non-profit consortium in order to establish a lipid formulation classification system.

Oral Formulation Driven by Bioavailability

Recently there has been a flow of collaborations and investments in the oral dose formulation sector as companies vie to lead the way in bioavailability.

This week in-Pharmatechnologist.com reported that Dow, Cambrex and Bend Research​ have formed a trifecta to tackle the issue, and Hovione and Solvias​ also teamed up late last year. Patheon, Catalent​ and Polypid​ have also heavily invested in oral dose formulation platforms. 

On the 20th​ March the Bioavailability Challenge will be addressed in a special online event, organized by in-Pharmatechnologist.com. For more information on speakers and how to gain access to the event, please click here​.

Related news

Show more

Related products

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers